E. Baltahi Et Al. , "Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report," TUMORI J , vol.88, no.6, pp.474-477, 2002
Baltahi, E. Et Al. 2002. Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report. TUMORI J , vol.88, no.6 , 474-477.
Baltahi, E., Altundag, M., Onat, D., Abbasoglu, O., Ozisik, Y., Guler, N., ... Atahan, L.(2002). Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report. TUMORI J , vol.88, no.6, 474-477.
Baltahi, E Et Al. "Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report," TUMORI J , vol.88, no.6, 474-477, 2002
Baltahi, E Et Al. "Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report." TUMORI J , vol.88, no.6, pp.474-477, 2002
Baltahi, E. Et Al. (2002) . "Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report." TUMORI J , vol.88, no.6, pp.474-477.
@article{article, author={E Baltahi Et Al. }, title={Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report}, journal={TUMORI J}, year=2002, pages={474-477} }